Cocrystal Pharma (COCP) Change in Account Payables (2010 - 2013)
Cocrystal Pharma (COCP) reported Change in Account Payables of -$1.5 million for Q3 2013, down 172.17% on a YoY basis from $2.1 million in Q3 2012, and down 488.14% sequentially from $385647.0 in Q2 2013.
Cocrystal Pharma (COCP) Change in Account Payables (2010 - 2013) Analysis & Trends
Cocrystal Pharma (COCP) has 4 years of Change in Account Payables data on file, last reported at -$1.5 million in Q3 2013.
- For the quarter ending Q3 2013, Change in Account Payables fell 172.17% year-over-year to -$1.5 million; the trailing twelve-month figure through Sep 2013 stood at -$701812.0 (up 57.74% YoY), and the FY2012 full-year result was -$880394.0, down 234.98% from the prior year.
- Change in Account Payables retreated to -$1.5 million in Q3 2013, from $385647.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.3 million in Q3 2011 to a low of -$1.5 million in Q3 2013.
- A 4-year average of -$114126.1 and a median of -$270618.0 in 2011 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 287.06% in 2011, while the deepest fall reached 482.03% in 2011.
- Tracing COCP's Change in Account Payables over 4 years: stood at -$189277.0 in 2010, then plunged by 482.03% to -$1.1 million in 2011, then jumped by 70.83% to -$321404.0 in 2012, then sank by 365.73% to -$1.5 million in 2013.
- Business Quant data shows COCP's Change in Account Payables at -$1.5 million in Q3 2013, $385647.0 in Q2 2013, and $730813.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | -1.50 Mn |
| Sep 30, 2013 | -1.50 Mn |
| Jun 30, 2013 | 385,647.00 |
| Jun 30, 2013 | 385,647.00 |
| Mar 31, 2013 | 730,813.00 |
| Mar 31, 2013 | 730,813.00 |
| Dec 31, 2012 | -321,404.00 |
| Dec 31, 2012 | -321,404.00 |
| Sep 30, 2012 | -549,969.00 |
| Sep 30, 2012 | -549,969.00 |
| Jun 30, 2012 | 437,483.00 |
| Jun 30, 2012 | 437,483.00 |
| Mar 31, 2012 | -446,504.00 |
| Mar 31, 2012 | -446,504.00 |
| Dec 31, 2011 | -1.10 Mn |
| Dec 31, 2011 | -1.10 Mn |
| Sep 30, 2011 | 1.28 Mn |
| Sep 30, 2011 | 1.28 Mn |
| Jun 30, 2011 | 741,672.00 |
| Jun 30, 2011 | 741,672.00 |